The dispute dates to 2013 when Apple sought Masimo’s technology to install pulse oximetry on its watch. Email correspondence ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Earlier this year, Apple stopped selling the Apple Watch Series 9 and Ultra 2 with blood oxygen features in the US following an International Trade Commission ruling that Apple infringed on Masimo ...

which started with the Masimo’s claim that its patents had been infringed by the Apple Watch’s pulse-oximetry feature, which allows Watch owners to measure their blood oxygen levels.

Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S ...

Masimo has previously accused Apple of hiring away its employees and copying aspects of its pulse oximetry technology following failed collaboration talks. Masimo scored a significant victory in ...

Irvine, California-based Masimo accused Apple of hiring away its employees and stealing its pulse oximetry technology after discussing a potential collaboration. Masimo convinced the U.S ...

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...